Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

Returns vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Ajanta Pharma Standalone September 2021 Net Sales At Rs 823.71 Crore, Up 21.76% Y-o-Y

Ajanta Pharma Q2 results: Profit up 15% at Rs 196 cr; board approves interim dividend

Ajanta Pharma consolidated net profit rises 15.11% in the September 2021 quarter

Shares of the company were trading 1.17 per cent down at Rs 2,102.80 apiece on the BSE

Ajanta Pharma second quarter profit rises 15% to Rs 196 crore

#CNBCAwaazLive #AajKaTajaKhabar #BusinessNewsLive #StockMarketLive #ShareMarketLive

Ajanta Pharma और BEL Stocks और कई दिग्गज Stocks पर समझें Prakash Gaba की Strategy, किस Stock में कैसे की जाए खरीदारी इस पर भी खास चर्चा, निवेशकों के हर सवालों का जवाब, देखें वीडियो

Share Market से जुड़ी हर छोटी या बड़ी खबर, चाहे हो Nifty में आए नए हाई या फिर, हो आपके के लिए स्टॉक्स पर राय, बिजनेस न्यूज हो या पॉलिटिकल न्यूज, कोरोनावायरस की न्यूज हो या फिर इलेक्शन, देखें CNBC Awaaz और रहे हर खबर से updated.


CNBC Awaaz is India’s number one business channel and an undisputed leader in business news and information for the last ten years. Our channel aims to educate, inform and inspire consumers to go beyond limitations, with practical tips on personal finance, investing, technology, consumer goods and capital markets. Policymakers and business owners alike have grown to trust CNBC Awaaz as the most reliable source with its eye on India’s business climate. Our programming gives consumers a platform to make decisions with confidence.

Subscribe to the CNBC Awaaz YouTube channel here: https://tinyurl.com/y5rsvesk

Follow CNBC Awaaz on Twitter: https://twitter.com/CNBC_Awaaz
Like us on our CNBC Awaaz Facebook page: https://www.facebook.com/cnbcawaaz
Website: https://bit.ly/3230WJW

Ajanta Pharma और BEL Stocks पर Prakash Gaba से जानें उनकी Strategy | CNBC Awaaz

Motilal Oswal is bullish on Ajanta Pharma recommended buy rating on the stock with a target price of Rs 2780 in its research report dated dated July 30, 2021.

Buy Ajanta Pharma; Target Of Rs 2780: Motilal Oswal

Ajanta Pharma Consolidated June 2021 Net Sales At Rs 747.99 Crore, Up 11.94% Y-o-Y

Ajanta Pharma Standalone June 2021 Net Sales At Rs 742.72 Crore, Up 32.43% Y-o-Y

Ajanta Pharma - Higher Forex Gains Aids Q1, Margin Sustenance To Drive Re-Rating: Dolat Capital

Ajanta Pharma’s consolidated net profit jumped 17.58% to Rs 173.75 crore on a 11.94% increase in revenue from operations to Rs 747.99 crore in Q1 June 2021 (Q1 FY22) over Q1 June 2020 (Q1 FY21).

Ajanta Pharma Q1 FY22 PAT grows 18% to Rs 174 cr

Tech Mahindra, TVS Motors Company, Colgate-Palmolive (India), Container Corporation of India, Laurus Labs, , Deepak Nitrite, Oberoi Realty, Union Bank of India, LIC Housing Finance and Ajanta Pharma are key companies which will announce June quarter earnings today.

Markets may consolidate post Fed meet; Tech Mahindra, TVS Motors in focus

Ajanta Pharma Limited is a specialty pharmaceutical company engaged in developing, producing and marketing a range of branded and generic formulations.

Ajanta Pharma Ltd

Ajanta Pharma Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Ajanta Pharma Standalone September 2021 Net Sales At Rs 823.71 Crore, Up 21.76% Y-o-Y

Ajanta Pharma Q2 results: Profit up 15% at Rs 196 cr; board approves interim dividend

Ajanta Pharma consolidated net profit rises 15.11% in the September 2021 quarter

Ajanta Pharma second quarter profit rises 15% to Rs 196 crore

News Video

Ajanta Pharma और BEL Stocks पर Prakash Gaba से जानें उनकी Strategy | CNBC Awaaz

Buy Ajanta Pharma; Target Of Rs 2780: Motilal Oswal

Ajanta Pharma Consolidated June 2021 Net Sales At Rs 747.99 Crore, Up 11.94% Y-o-Y

Ajanta Pharma Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Ajanta Pharma Standalone September 2021 Net Sales At Rs 823.71 Crore, Up 21.76% Y-o-Y

Ajanta Pharma Q2 results: Profit up 15% at Rs 196 cr; board approves interim dividend

Ajanta Pharma consolidated net profit rises 15.11% in the September 2021 quarter

Ajanta Pharma second quarter profit rises 15% to Rs 196 crore

News Video

Ajanta Pharma और BEL Stocks पर Prakash Gaba से जानें उनकी Strategy | CNBC Awaaz

Buy Ajanta Pharma; Target Of Rs 2780: Motilal Oswal

Ajanta Pharma Consolidated June 2021 Net Sales At Rs 747.99 Crore, Up 11.94% Y-o-Y

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock